Trial Profile
A Multicenter, Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization Against Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilus Influenza Type B in Infants
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Feb 2017
Price :
$35
*
At a glance
- Drugs Hib DTP hepatitis B vaccine LG Chem (Primary)
- Indications Diphtheria; Hepatitis B; Influenza B virus infections; Pertussis; Tetanus
- Focus Adverse reactions
- Sponsors LG Life Sciences
- 09 Oct 2014 New trial record